New depression Drug's safety tracked in 800+ patients

NCT ID NCT05061719

Completed Disease control Sponsor: Intra-Cellular Therapies, Inc. Source: ClinicalTrials.gov ↗

Summary

This study aimed to check the long-term safety of adding a new medication called lumateperone to standard antidepressant therapy for people with major depression. Over 800 patients who had already completed a prior study took lumateperone daily for about six months while continuing their regular treatment. Researchers closely monitored for side effects and changes in depression symptoms to see if the combination was safe and tolerable over a longer period.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Clinical SIte

Torun, 87-100, Poland
Clinical Site

Phoenix, Arizona, 85012, United States
Clinical Site

Bentonville, Arkansas, 72712, United States
Clinical Site

Little Rock, Arkansas, 72211, United States
Clinical Site

Rogers, Arkansas, 72758, United States
Clinical Site

Culver City, California, 90230, United States
Clinical Site

Glendale, California, 91206, United States
Clinical Site

Newport Beach, California, 92660, United States
Clinical Site

Oceanside, California, 92056, United States
Clinical Site

Redlands, California, 92374, United States
Clinical Site

Riverside, California, 92506, United States
Clinical Site

San Diego, California, 92103, United States
Clinical Site

Sherman Oaks, California, 91403, United States
Clinical Site

Temecula, California, 92951, United States
Clinical Site

Upland, California, 91786, United States
Clinical Site

Fort Lauderdale, Florida, 33319, United States
Clinical Site

Jacksonville, Florida, 32256, United States
Clinical Site

Orlando, Florida, 32801, United States
Clinical Site

Palm Bay, Florida, 32905, United States
Clinical Site

West Palm Beach, Florida, 33407, United States
Clinical Site

Atlanta, Georgia, 30328, United States
Clinical Site

Atlanta, Georgia, 30329, United States
Clinical Site

Atlanta, Georgia, 30331, United States
Clinical Site

Decatur, Georgia, 30030, United States
Clinical Site

Joliet, Illinois, 60435, United States
Clinical Site

Overland Park, Kansas, 66211, United States
Clinical Site

Gaithersburg, Maryland, 20877, United States
Clinical Site

Boston, Massachusetts, 02131, United States
Clinical Site

Flowood, Mississippi, 39232, United States
Clinical Site

Saint Charles, Missouri, 63304, United States
Clinical Site

Berlin, New Jersey, 08009, United States
Clinical Site

Toms River, New Jersey, 08755, United States
Clinical Site

Brooklyn, New York, 11235, United States
Clinical Site

Cedarhurst, New York, 11516, United States
Clinical Site

Mount Kisco, New York, 10549, United States
Clinical Site

Charlotte, North Carolina, 28211, United States
Clinical Site

Allentown, Pennsylvania, 18104, United States
Clinical Site

Media, Pennsylvania, 19063, United States
Clinical Site

Plymouth Meeting, Pennsylvania, 19462, United States
Clinical Site

Austin, Texas, 78737, United States
Clinical Site

Bellevue, Washington, 98007, United States
Clinical Site

Burgas, 8001, Bulgaria
Clinical Site

Kazanlak, 6100, Bulgaria
Clinical Site

Novi Iskar, 1282, Bulgaria
Clinical Site

Pleven, 5809, Bulgaria
Clinical Site

Plovdiv, 4004, Bulgaria
Clinical Site

Rousse, 7003, Bulgaria
Clinical Site

Sofia, 1408, Bulgaria
Clinical Site

Sofia, 1680, Bulgaria
Clinical Site

Targovishte, 7700, Bulgaria
Clinical Site

Tsarev Brod, 9747, Bulgaria
Clinical Site

Veliko Tarnovo, 5000, Bulgaria
Clinical Site

Veliko Tarnovo, 5047, Bulgaria
Clinical Site

Vratsa, 3001, Bulgaria
Clinical Site

Brno, 60200, Czechia
Clinical Site

Hostivice, 253 01, Czechia
Clinical Site

Ostrava, 708 00, Czechia
Clinical Site

Pilsen, 301 00, Czechia
Clinical Site

Prague, 100 00, Czechia
Clinical Site

Prague, 160 00, Czechia
Clinical Site

Prague, 186 00, Czechia
Clinical Site

Helsinki, 00100, Finland
Clinical Site

Oulu, 90100, Finland
Clinical Site

Bad Homburg, 61348, Germany
Clinical Site

Freiburg im Breisgau, 79104, Germany
Clinical Site

Hamburg, 20253, Germany
Clinical Site

Mittweida, 09648, Germany
Clinical Site

Schwerin, 19053, Germany
Clinical Site

Westerstede, 26655, Germany
Clinical Site

Budapest, 1033, Hungary
Clinical Site

Budapest, 1083, Hungary
Clinical Site

Budapest, 1134, Hungary
Clinical Site

Budapest, 1135, Hungary
Clinical Site

Debrecen, 4032, Hungary
Clinical Site

Gyöngyös, 3200, Hungary
Clinical Site

Guwahati, Assam, 781010, India
Clinical Site

Ahmedabad, Gujarat, 380013, India
Clinical Site

Jūnāgadh, Gujarat, 362001, India
Clinical Site

Vadodara, Gujarat, 390021, India
Clinical Site

Mysore, Karnataka, 570001, India
Clinical Site

Aurangabad, Maharashtra, 431005, India
Clinical Site

Nagpur, Maharashtra, 440010, India
Clinical Site

Nashik, Maharashtra, 422001, India
Clinical Site

Mumbai, 400008, India
Clinical Site

Nashik, 422005, India
Clinical Site

Bełchatów, 97-400, Poland
Clinical Site

Bialystok, 15-404, Poland
Clinical Site

Bialystok, 15-464, Poland
Clinical Site

Bialystok, 15-879, Poland
Clinical Site

Bydgoszcz, 85-080, Poland
Clinical Site

Gdansk, 80-546, Poland
Clinical Site

Gorlice, 38-300, Poland
Clinical Site

Leszno, 64-100, Poland
Clinical Site

Pruszcz Gdański, 83-000, Poland
Clinical Site

Wroclaw, 50-414, Poland
Clinical Site

Bratislava, 82007, Slovakia
Clinical Site

Košice, 04001, Slovakia
Clinical Site

Rimavská Sobota, 979 01, Slovakia
Clinical Site

Svidník, 089 01, Slovakia
Clinical Site

Vranov nad Topľou, 09301, Slovakia
Clinical Site

Zlaté Moravce, 953 01, Slovakia
Clinical Site

Ansan-si, North Chungcheong, 15355, South Korea
Clinical Site

Gwangju, 61469, South Korea
Clinical Site

Seoul, 01830, South Korea
Clinical Site

Seoul, 03080, South Korea
Clinical Site

Seoul, 06351, South Korea
Clinical Site

Lund, 22222, Sweden
Clinical Site

Stockholm, 11329, Sweden
Clinical site

Brno, 615 00, Czechia

Conditions

Explore the condition pages connected to this study.

MAJOR DEPRESSIVE DISORDER